SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,256,147 | -31.0% | 158,219 | +57.6% | 0.00% | -50.0% |
| Q2 2023 | $4,719,021 | +187.5% | 100,362 | +156.5% | 0.00% | +100.0% |
| Q1 2023 | $1,641,559 | -52.0% | 39,122 | -56.3% | 0.00% | -50.0% |
| Q4 2022 | $3,417,420 | +80.4% | 89,602 | +52.8% | 0.00% | +100.0% |
| Q2 2022 | $1,894,000 | -75.2% | 58,625 | -74.6% | 0.00% | -50.0% |
| Q1 2022 | $7,646,000 | -2.3% | 231,012 | +25.5% | 0.00% | 0.0% |
| Q4 2021 | $7,828,000 | +2.6% | 184,028 | +6.9% | 0.00% | 0.0% |
| Q3 2021 | $7,626,000 | -78.2% | 172,081 | -72.1% | 0.00% | -85.7% |
| Q2 2021 | $35,005,000 | +80.9% | 616,168 | +138.3% | 0.01% | +55.6% |
| Q1 2021 | $19,351,000 | +2.0% | 258,530 | +17.9% | 0.01% | 0.0% |
| Q4 2020 | $18,968,000 | +24.9% | 219,255 | -11.8% | 0.01% | 0.0% |
| Q3 2020 | $15,190,000 | +60.9% | 248,538 | +9.5% | 0.01% | +28.6% |
| Q2 2020 | $9,440,000 | +1400.8% | 227,028 | +936.7% | 0.01% | – |
| Q1 2020 | $629,000 | -93.1% | 21,900 | -82.6% | 0.00% | -100.0% |
| Q4 2019 | $9,081,000 | +413.1% | 125,784 | +896.7% | 0.01% | +333.3% |
| Q3 2019 | $1,770,000 | +36.0% | 12,620 | +77.7% | 0.00% | +50.0% |
| Q2 2019 | $1,301,000 | -77.4% | 7,102 | -80.4% | 0.00% | -80.0% |
| Q1 2019 | $5,755,000 | +632.2% | 36,183 | +340.9% | 0.01% | +400.0% |
| Q4 2018 | $786,000 | -87.9% | 8,206 | -80.2% | 0.00% | -86.7% |
| Q2 2018 | $6,504,000 | +1441.2% | 41,549 | +1487.1% | 0.02% | +1400.0% |
| Q1 2018 | $422,000 | -82.8% | 2,618 | -82.4% | 0.00% | -85.7% |
| Q4 2017 | $2,450,000 | +199.9% | 14,872 | +13.4% | 0.01% | +133.3% |
| Q3 2017 | $817,000 | +292.8% | 13,118 | +349.1% | 0.00% | +200.0% |
| Q1 2017 | $208,000 | -47.1% | 2,921 | -65.7% | 0.00% | -50.0% |
| Q3 2016 | $393,000 | +22.0% | 8,524 | -20.3% | 0.00% | 0.0% |
| Q2 2016 | $322,000 | +10.3% | 10,700 | +17.6% | 0.00% | 0.0% |
| Q1 2016 | $292,000 | – | 9,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |